Park Place Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$944K Buy
4,275
+2,372
+125% +$656K 0.15% 96
2026
Q1
$562K Buy
1,903
+546
+40% +$162K 0.11% 115
2025
Q4
$371K Buy
1,357
+668
+97% +$182K 0.08% 136
2025
Q3
$186K Buy
689
+641
+1,335% +$174K 0.04% 200
2025
Q2
$13.2K Buy
48
+36
+300% +$9.79K ﹤0.01% 539
2025
Q1
$3.18K Hold
12
﹤0.01% 697
2024
Q4
$2.79K Hold
12
﹤0.01% 702
2024
Q3
$2.65K Hold
12
﹤0.01% 745
2024
Q2
$2.36K Sell
12
-65
-84% -$13.4K ﹤0.01% 761
2024
Q1
$16.6K Hold
77
0.01% 567
2023
Q4
$16.2K Sell
77
-405
-84% -$86.4K 0.01% 568
2023
Q3
$96.5K Buy
482
+30
+7% +$5.96K 0.03% 356
2023
Q2
$83.8K Buy
452
+47
+12% +$8.69K 0.02% 395
2023
Q1
$77.6K Buy
405
+21
+5% +$3.8K 0.02% 403
2022
Q4
$65K Buy
+384
New +$66.7K 0.02% 443

Other funds holding CME

Park Place Capital's CME Position: Q2 2026 in Review

Park Place Capital increased its CME Group (CME) stake by 125% in Q2 2026, buying an estimated $656K and bringing the position to 4,275 shares worth $944K. The position accounts for 0.15% of the portfolio, ranked #96.

Park Place Capital first reported a position in CME in Q4 2022 and has held it in 15 quarters since. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Park Place Capital held 4,275 shares of CME Group worth $944K as of Q2 2026.
  • Park Place Capital bought 2,372 CME Group shares in Q2 2026, an estimated $656K.
  • CME Group made up 0.15% of Park Place Capital's portfolio in Q2 2026, its #96 holding.
  • Park Place Capital first reported a position in CME Group in Q4 2022 and has held it in 15 quarters since.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.